Company Filing History:
Years Active: 1999
Title: The Innovative Contributions of Jeff Mooney
Introduction: Jeff Mooney, hailing from Limerick, PA, is a notable inventor with significant contributions in the field of biotechnology. With one patent to his name, he has made a substantial impact on research surrounding antibiotic compounds.
Latest Patents: One of Jeff Mooney's most significant achievements is his patent for "DNA encoding the SecA1 polypeptide of Staphylococcus aureus." This invention focuses on the secA1 polypeptides and the DNA (RNA) that encodes these polypeptides. Additionally, it outlines methods to produce these polypeptides through recombinant techniques. The invention also discusses how secA1 polypeptides can be utilized to screen for antibacterial compounds, showcasing its relevance in developing new treatments against bacterial infections.
Career Highlights: Jeff Mooney is associated with SmithKline Beecham Corporation, a leading name in the pharmaceutical and healthcare sectors. His work in this organization has advanced the understanding and production of bacterial components, which are crucial for developing new antibacterial therapies.
Collaborations: Throughout his career, Jeff has collaborated with notable colleagues such as Karen M O'Dwyer and Serry Sousa. Their collective efforts have contributed to the enhancement of research and innovation within their field, paving the way for new advancements in medical science.
Conclusion: Jeff Mooney's innovations and dedication to advancing healthcare through his patent on SecA1 polypeptides highlight the importance of research and development in combating antibiotic resistance. His work not only demonstrates individual achievement but also reflects the collaborative spirit that drives progress in the scientific community.